These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12875622)
21. Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese. Hishida A; Matsuo K; Tajima K; Ogura M; Kagami Y; Taji H; Morishima Y; Emi N; Naoe T; Hamajima N Leuk Lymphoma; 2004 May; 45(5):957-64. PubMed ID: 15291355 [TBL] [Abstract][Full Text] [Related]
22. Association of p73 G4C14-to-A4T14 polymorphism with lung cancer risk. Liu H; Liang Y; Liao H; Li L; Wang H Tumour Biol; 2014 Sep; 35(9):9311-6. PubMed ID: 24943681 [TBL] [Abstract][Full Text] [Related]
23. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883 [TBL] [Abstract][Full Text] [Related]
24. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488 [TBL] [Abstract][Full Text] [Related]
25. [Correlation of p73 polymorphisms to genetic susceptibilities to esophageal carcinoma and gastric cardiac carcinoma]. Ge H; Wang YM; Cao YY; Zhang XF; Li Y; Guo W; Wang N; Zhang JH Ai Zheng; 2006 Nov; 25(11):1351-5. PubMed ID: 17094900 [TBL] [Abstract][Full Text] [Related]
26. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene. Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786 [TBL] [Abstract][Full Text] [Related]
27. Age-related function of tumor suppressor gene TP53:contribution to cancer risk and progression. Cherdyntseva NV; Gervas PA; Litvyakov NV; Stakcheeva MN; Ponomaryeva AA; Dobrodeev AY; Denisov EV; Belyavskaya VA; Choinzonov EL Exp Oncol; 2010 Sep; 32(3):205-8. PubMed ID: 21403619 [TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156 [TBL] [Abstract][Full Text] [Related]
29. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer. Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617 [TBL] [Abstract][Full Text] [Related]
30. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer. Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356 [TBL] [Abstract][Full Text] [Related]
31. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer. Sanz-Ortega J; Roig F; Al-Mousa MM; Saez MC; Muñoz A; Sanz-Esponera J; Callol L Histol Histopathol; 2007 May; 22(5):541-5. PubMed ID: 17330809 [TBL] [Abstract][Full Text] [Related]
32. P73 G4C14-to-A4T14 polymorphism is associated with survival in advanced non-small cell lung cancer patients. Ge L; Yang Y; Sun Y; Xu W; Lu D; Su B Thorac Cancer; 2017 Mar; 8(2):63-72. PubMed ID: 28134496 [TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. Liu G; Wheatley-Price P; Zhou W; Park S; Heist RS; Asomaning K; Wain JC; Lynch TJ; Su L; Christiani DC Int J Cancer; 2008 Feb; 122(4):915-8. PubMed ID: 17957785 [TBL] [Abstract][Full Text] [Related]
34. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms. Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853 [TBL] [Abstract][Full Text] [Related]
35. Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects. Niwa Y; Hirose K; Matsuo K; Tajima K; Ikoma Y; Nakanishi T; Nawa A; Kuzuya K; Tamakoshi A; Hamajima N Cancer Lett; 2005 Mar; 219(2):183-90. PubMed ID: 15723718 [TBL] [Abstract][Full Text] [Related]
36. Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population. Kiyohara C; Horiuchi T; Miyake Y; Takayama K; Nakanishi Y Oncol Rep; 2010 May; 23(5):1361-8. PubMed ID: 20372852 [TBL] [Abstract][Full Text] [Related]
37. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province, Iran. Nadji SA; Mahmoodi M; Ziaee AA; Naghshvar F; Torabizadeh J; Yahyapour Y; Nategh R; Mokhtari-Azad T Lung Cancer; 2007 May; 56(2):145-51. PubMed ID: 17208332 [TBL] [Abstract][Full Text] [Related]
38. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504 [TBL] [Abstract][Full Text] [Related]
39. Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status. Domínguez G; Silva J; Silva JM; García JM; Larrondo FJ; Vargas J; Sanfrutos L; Provencio M; España P; Bonilla F Genes Chromosomes Cancer; 2001 Jun; 31(2):99-106. PubMed ID: 11319797 [TBL] [Abstract][Full Text] [Related]
40. Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma. Wang Y; Kringen P; Kristensen GB; Holm R; Baekelandt MM; Olivier M; Skomedal H; Hainaut P; Tropé CG; Abeler VM; Nesland JM; Børresen-Dale AL; Helland A Hum Mutat; 2004 Jul; 24(1):21-34. PubMed ID: 15221786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]